ENDRA Life Sciences Inc. (NAS: NDRA) Stock Analysis & Fundamentals | ScreenerHero

Create free account

NDRAENDRA Life Sciences Inc.

NAS · US · Healthcare · Diagnostics & Research · endrainc.com

5.270USD-6.06%Mkt Cap: 6.69M $P/E: —1d ago

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed …

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap6.69M $

Enterprise Value6.80M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-7.03M $

Revenue/Share—

Last Price5.270 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees9

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.73

PEG—

EV/EBITDA-1.06

EV/Revenue—

P/S—

P/B3.66

EPS (TTM)-8.16

EPS (Forward)-3.04

52W Range

2.96034% of range9.850

52W High9.850 USD

52W Low2.960 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-310.93%

ROA-182.35%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-5.18M $

CapEx (TTM)3.02M $

FCF Margin—

FCF Yield-81.02%

Net Debt104.74K $

Net Debt/EBITDA-0.02

Balance Sheet

Debt/Equity0.22

Current Ratio0.64

Quick Ratio0.43

Book Value/Sh1.440 USD

Cash/Share0.2810 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:35

Split DateNov 7, 2024

Analyst Consensus

Rating—

Target (Mean)25.00 USD

Upside (mean)+374.4%

Target Range25.00 USD – 25.00 USD

# Analysts1

Ownership

Shares Out.1.27M

Float1.20M

Insiders8.73%

Institutions9.66%

Short Interest

Short Ratio0.9d

Short % Float3.51%

Short % Out.3.32%

Shares Short42.12K

Short (prev mo.)19.82K

Technical

SMA 505.095 (+3.4%)

SMA 2004.950 (+6.5%)

Beta-0.05

S&P 52W Chg20.25%

Avg Vol (30d)45.11K

Avg Vol (10d)38.72K

Technical Indicators

RSI (14)51.5

MACD0.1291

MACD Signal0.0814

MACD Hist.+0.0477

BB Upper6.045 USD

BB Middle5.168 USD

BB Lower4.291 USD

BB Width33.95%

ATR (14)0.6242 USD

Vol Ratio (20d)0.45x